AiViva BioPharma

AiVivia is developing drug products with the potential to transform treatment paradigms or significantly reduce the treatment burden for patients and physicians. Their approach leverages the proprietary JEL™ Technology to prolong the therapeutic effects of drugs and enhance the benefit-risk profiles. AiViva has a diverse pipeline of multiple novel drug candidates in development areas of dermatology, ophthalmology, oncology, and urology with the potential to expand to other areas of interest.